The estimated Net Worth of Robin Campbell is at least $2.83 Milhão dollars as of 22 August 2018. Robin Campbell owns over 5,000 units of Pfenex stock worth over $2,829,000 and over the last 10 years Robin sold PFNX stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Robin Campbell PFNX stock SEC Form 4 insiders trading
Robin has made over 1 trades of the Pfenex stock since 2018, according to the Form 4 filled with the SEC. Most recently Robin bought 5,000 units of PFNX stock worth $24,250 on 22 August 2018.
The largest trade Robin's ever made was buying 5,000 units of Pfenex stock on 22 August 2018 worth over $24,250. On average, Robin trades about 556 units every 0 days since 2014. As of 22 August 2018 Robin still owns at least 5,000 units of Pfenex stock.
You can see the complete history of Robin Campbell stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Robin Campbell's mailing address?
Robin's mailing address filed with the SEC is C/O PFENEX INC., 10790 ROSELLE STREET, , SAN DIEGO, CA, 92121.
Insiders trading at Pfenex
Over the last 10 years, insiders at Pfenex have traded over $99,496,796 worth of Pfenex stock and bought 36,000 units worth $174,640 . The most active insiders traders include Chemical Co /De/ Dow, James C Gale, eHealthcare Partners Accredi.... On average, Pfenex executives and independent directors trade stock every 46 days with the average trade being worth of $90,240,574. The most recent stock trade was executed by Asset Management Lpweiss An... on 29 September 2020, trading 100,000 units of PFNX stock currently worth $1,274,000.
What does Pfenex do?
Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.
What does Pfenex's logo look like?
Complete history of Robin Campbell stock trades at Pfenex
Pfenex executives and stock owners
Pfenex executives and other stock owners filed with the SEC include:
-
Shawn Scranton,
Chief Operating Officer -
Susan A. Knudson,
Chief Financial Officer -
Evert B. Schimmelpennink,
See Remarks -
Patricia Lady,
Chief Accounting Officer -
Jason Grenfell Gardner,
Director -
Martin Brenner,
Chief Scientific Officer -
Magda Marquet,
Director -
Phillip M Schneider,
Director -
Sigurdur O Olafsson,
Director -
Hubert C Chen,
Chief Medical Officer -
John Mack Taylor,
Director -
Patrick K. Lucy,
Chief Business Officer -
Robin Campbell,
Director -
Lorianne Masuoka,
Director -
Dennis M Fenton,
Director -
William R Rohn,
Director -
Henry W. Jr. Talbot,
VP of Research & Operations -
Healthcare Partners Accredi...,
10% owner -
Bertrand C. Liang,
Chief Executive Officer -
Steven S. Sr. Sandoval,
Chief Manufacturing Officer -
Paul A. Wagner,
Chief Financial Officer -
Chemical Co /De/ Dow,
10% owner -
Healthcare Partners Accredi...,
-
James C Gale,
Director -
Asset Management Lpweiss An...,
-
Management, Llc Newtyn,
10% owner